82%
Confidence and control over your clinical study
Lindus trials that completed enrollment
on or ahead of proposed timeline [1]
on or ahead of proposed timeline [1]
20%
Industry average for trials that completed
enrollment on initial timeline [2]
enrollment on initial timeline [2]
[1] Measured against all 28 trials that completed enrollment within the past 3 years, where Lindus was responsible for enrollment.
[2] Desai M. Recruitment and retention of participants in clinical studies: critical issues and challenges. Perspect Clin Res. 2020;11(2):51-53. doi:10.4103/picr.PICR_6_20
[2] Desai M. Recruitment and retention of participants in clinical studies: critical issues and challenges. Perspect Clin Res. 2020;11(2):51-53. doi:10.4103/picr.PICR_6_20
Prof. Robert S. Langer
Founder of Moderna,
40+ Biotech companies
“Lindus’ integrated approach to clinical trial execution, performance-based commercial model, and novel AI trial operating system has been incredibly helpful to biotech and pharmaceutical companies, enabling them to bring new therapies to market faster and more efficiently.”
Dr. Stephen Deacon
Chief Scientific Officer, Pharmanovia
“In the past I’ve felt like most of my interactions with CROs were about change orders; having a real partner with cost certainty is a game changer.”
Awards
Outstanding Patient Recruitment & Retention
2025
Best Contract Research Organization — Finalist
2025
AI Innovation Challenge — Finalist
2025
We don't bill for delays.
We prevent them.
A community setting a new standard for accountability
Putting you back in control
Real-time visibility. Shared operational truth.
Engineered to manage studies like data pipelines. Recruitment, study operations, and clinical data all run through one system, so risks surface early. Enrollment performance and data completeness are visible to both sponsors and Lindus teams. Early identification. Faster action.
Performance-based commercial model.
Contracts structured around milestone delivery and operational performance. Financial incentives sit where yours do — on timelines landing and budgets holding.
Integrated execution platform. Designed to adapt. Operated by one accountable team.
Study design through execution in one path, powered by AI and purpose-built technology. Sites underenrolling? Recruit patients directly from the community. Adherence off track? Deploy additional coordinator support. Under 12% annual team turnover — less than half the industry average. Accountability is clear, unfragmented, and personal.
Expertise
Cardiometabolic
Respiratory
Neuropsychiatry
Dermatology
Women’s health
Diagnostics
Geographic footprint
Core presence
Integrated partnership
Eric Haltom
SVP Clinical Operations
“We felt like another fish in the big pond with the larger CROs. Lindus is a tight-knit team, an extension of my team — truly your partner, in it to win it on the execution.”
Dr. Stephen Deacon
Chief Scientific Officer
“In the past I’ve felt like most of my interactions with CROs were about change orders; having a real partner with cost certainty is a game changer.”
Akash Bijlani
Director Global Market Access
“Working with the Lindus team has forever changed our experience running clinical trials. They have a can-do attitude and make things happen, going above and beyond the call of duty.”
Dr. Robert S. Langer
Founder
"Lindus’s approach to clinical trial execution and their associated technologies should be incredibly helpful to biotech and pharmaceutical companies."
Dr. Navid Khodaparast
Chief Scientific Officer
“Lindus has been a great partner in conducting our research. They treated our trial as if it were their own, demonstrating dedication and transparency every step of the way."
Dr. Jameel Muzaffar
Chief Science Officer
“Lindus delivered our fully decentralized trial on time and on budget. They were responsive, professional, and adaptable, with really impressive modern systems that made enrollment feel seamless."
Dr. Steven Chavoustie
Principal Investigator
“Lindus knows what they’re doing! They have been great to work with. So fast to respond and so helpful. Their Citrus operating system is very user-friendly and night & day compared to Rave and MediData.”
Dr. Tim Garnett
Former CMO
“Lindus puts great emphasis on aligning incentives with sponsors, and their risk-sharing, milestone-based payment model is much needed in the CRO industry. Their patient and technology-centric approach to clinical trials will greatly benefit biotech and pharma."
Mark Wutke
Chief Executive Officer
“We've had a great experience working with Lindus. We found them to be proactive, transparent, and they delivered what they said they would on time and on budget. When situations warranted change, they worked with us in the best way to get there.”
David Zakariaie
Chief Executive Officer
"Partnering with Lindus has been a game-changer. Their team impressed us with their high level of proactivity and inventive approaches to mitigating potential roadblocks. They deeply understood the nuances of our technology and tailored our study design."
Mr. Matthew Smith
Chief Principal Investigator
"Lindus is extremely professional and has a diverse, knowledgeable team that provides the advice and skilled staff we needed. I was impressed by the efficiency of the trial delivery on a tight timescale, excellent communication, and flexibility."